Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The price of Milestone Pharmaceuticals Inc (NASDAQ: MIST) closed at $1.23 in the last session, down -8.89% from day before closing price of $1.35. In other words, the price has decreased by -$8.89 from its previous closing price. On the day, 1.92 million shares were traded.
Ratios:
We take a closer look at MIST’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 9.10 and its Current Ratio is at 9.10. In the meantime, Its Debt-to-Equity ratio is 4.17 whereas as Long-Term Debt/Eq ratio is at 4.12.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on August 22, 2024, initiated with a Buy rating and assigned the stock a target price of $9.
On June 20, 2023, Jefferies Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $8 to $4.
Piper Sandler Upgraded its Neutral to Overweight on April 22, 2022, whereas the target price for the stock was revised from $8 to $10.
Stock Price History:
Over the past 52 weeks, MIST has reached a high of $2.75, while it has fallen to a 52-week low of $0.63. The 50-Day Moving Average of the stock is -17.86%, while the 200-Day Moving Average is calculated to be -25.33%.
Shares Statistics:
A total of 53.35M shares are outstanding, with a floating share count of 50.79M. Insiders hold about 4.81% of the company’s shares, while institutions hold 34.80% stake in the company.
